Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study

Clinical trial NCT06503900 · COMPLETED

Trial details

NCT number: NCT06503900
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Birth Outcomes Safety Adverse Event Following Immunization

Start date: 2024-09-12
Primary completion: 2025-08-20
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.